Publication:
Heart rate variability in beta-thalassemia patients

dc.contributor.authorWasarut Rutjanapromen_US
dc.contributor.authorNatnicha Kanlopen_US
dc.contributor.authorPimlak Charoenkwanen_US
dc.contributor.authorRekwan Sittiwangkulen_US
dc.contributor.authorSomdet Srichairatanakoolen_US
dc.contributor.authorAdisak Tantiworawiten_US
dc.contributor.authorArintaya Phrommintikulen_US
dc.contributor.authorSiriporn Chattipakornen_US
dc.contributor.authorSuthat Fucharoenen_US
dc.contributor.authorNipon Chattipakornen_US
dc.contributor.otherChiang Mai Universityen_US
dc.contributor.otherThe Institute of Science and Technology for Research and Development, Mahidol Universityen_US
dc.date.accessioned2018-09-13T06:52:15Z
dc.date.available2018-09-13T06:52:15Z
dc.date.issued2009-11-01en_US
dc.description.abstractBackground: Cardiac failure remains the major cause of death in beta-thalassemia major (TM). Reduced heart rate variability (HRV) is associated with a higher risk of arrhythmias after myocardial infarction and heart failure. We evaluated HRV in TM patients and its relationship with hemodynamics and echocardiographic parameters during a 6-month follow-up. Methods: Thirty-four TM patients (19 ± 10 yr) and 20 healthy subjects (17 ± 6 yr) were evaluated. Hematologic, biochemical, echocardiographic and HRV parameters were determined at entry and at 6-month follow-up. Time and frequency domain HRV parameters were analyzed from 24-h recorded electrocardiograms. All TM patients received blood transfusion and chelation therapy. Results: Both time and frequency domain HRV parameters were markedly reduced in TM patients, compared to the control. The significantly improved HRV was seen in correlation with higher hemoglobin (Hb) level when compared within TM group at different time point. No correlation was seen between HRV and serum ferritin, reactive oxygen species (ROS) and non-transferrin bound iron (NTBI). Conclusion: HRV is depressed in TM patients. HRV was significantly correlated with Hb level, suggesting that anemia greatly influences the cardiac autonomic balance. © 2009 John Wiley & Sons A/S.en_US
dc.identifier.citationEuropean Journal of Haematology. Vol.83, No.5 (2009), 483-489en_US
dc.identifier.doi10.1111/j.1600-0609.2009.01314.xen_US
dc.identifier.issn16000609en_US
dc.identifier.issn09024441en_US
dc.identifier.other2-s2.0-70349952482en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/27881
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=70349952482&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleHeart rate variability in beta-thalassemia patientsen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=70349952482&origin=inwarden_US

Files

Collections